T-cell engagement with a difference
In8bio joins Lava in going beyond basic CD3-based T-cell engager MAbs.
ASH 2024 – J&J reveals more about Lava's secret sauce
JNJ-89853413 is disclosed as the lead in the two companies' 2020 alliance.
Pfizer isn’t done with CD47
Maplirpacept features among key biologicals and small molecules highlighted at Pfizer’s oncology update.
